Back to results
US 2020/0038526 A1Published application
Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-128
AssigneeAdvanced Accelerator Applications International SA
InventorsLorenza Fugazza, Maurizio Franco Mariani, Francesca Orlandi, Daniela Chicco, Donato Barbato
Life of this patent
Estimating the term…
Abstract
It is described a composition comprising lyophilized rhAnnexin V-128 suitable for the preparation of 99mTc-rhAnnexin V-128 formulations suitable for intravenous administration.
Claims16
A lyophilized composition suitable for intravenous administration comprising rhAnnexin V-128 in combination with an antioxidant agent, in a pH range of 5.0-6.6.
9-13. (canceled)
Dependencies are inferred from the claim text.